Archives

  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Gut Microbiota-Derived H2S Reduces GLP-1, Impairing Metaboli

    2026-06-23

    Hydrogen Sulfide from Gut Microbiota: A Mechanistic Link to Impaired GLP-1 and Metabolic Dysfunction

    Study Background and Research Question

    The gut microbiota has emerged as a key regulator of host metabolic health, influencing obesity, type 2 diabetes, and cardiovascular disease. While microbial metabolites such as trimethylamine have been linked to metabolic syndrome (MetS), the full spectrum of gut-derived factors affecting host metabolism remains incompletely understood. Many metabolites do not cross the gut barrier, suggesting localized relay effects on host cells. The present study addresses a critical gap: whether and how specific gut microbes modulate enteroendocrine function and key metabolic hormones, particularly glucagon-like peptide 1 (GLP-1), which is central to glucose homeostasis and satiety.

    Key Innovation from the Reference Study

    This research identifies Desulfovibrio—an intestinal symbiont enriched in MetS patients—as a direct suppressor of GLP-1 production via hydrogen sulfide (H2S) generation. Unlike previous studies focusing on systemic metabolites, the authors reveal a localized interaction: Desulfovibrio-derived H2S inhibits mitochondrial respiration and activates the unfolded protein response specifically in intestinal L cells, thereby reducing GLP-1 gene expression and secretion. Importantly, pharmacological blockade of Desulfovibrio-H2S signaling restores GLP-1 levels and improves metabolic parameters in mouse models of diet-induced obesity, establishing a causal link in the microbe-metabolite-host axis.

    Methods and Experimental Design Insights

    The experimental approach combined gnotobiotic mouse models, targeted microbial manipulation, and metabolic phenotyping. Tcrb−/− mice (deficient in T cells) were either reconstituted with wild-type T cells or co-housed with wild-type mice to modulate their gut microbiota composition. Microbiota profiling, metabolic hormone quantification, and glucose challenge assays established the relationship between Desulfovibrio abundance and plasma GLP-1 levels. In vitro and ex vivo experiments using isolated intestinal L cells assessed the direct effects of H2S on mitochondrial function and hormone secretion. Further, bismuth subsalicylate—a clinically available antimicrobial—was used to selectively inhibit Desulfovibrio and H2S production in vivo, enabling causal interrogation of this pathway in metabolic disease models.

    Protocol Parameters

    • Microbiota manipulation: Tcrb−/− mice co-housed or reconstituted with T cells for 4 weeks to adjust gut microbial profiles.
    • GLP-1 quantification: Active GLP-1 measured by ELISA in blood samples collected at rest and after oral glucose challenge.
    • Microbial profiling: Bray–Curtis dissimilarity and Shannon index calculated from 16S rRNA gene sequencing of fecal samples.
    • Desulfovibrio inhibition: Bismuth subsalicylate administered orally; dosing optimized to reduce Desulfovibrio without global microbiome disruption.
    • Cellular assays: L cell mitochondrial respiration and unfolded protein response evaluated after exposure to defined concentrations of H2S.

    Core Findings and Why They Matter

    The study demonstrates a strong inverse correlation between Desulfovibrio abundance and GLP-1 levels in both dysbiosis and diet-induced obesity models. Mechanistically, Desulfovibrio-derived H2S inhibits mitochondrial respiration within L cells, triggering an unfolded protein response that suppresses GLP-1 gene expression and hormone secretion. Intervention with bismuth subsalicylate significantly reduced Desulfovibrio and H2S, restored GLP-1 secretion, and improved glucose tolerance and metabolic outcomes in male mice. These results establish a direct microbial-metabolite-endocrine axis driving metabolic dysfunction, with GLP-1 suppression as a key effector event. This mechanistic insight expands our understanding of how the gut microbiome orchestrates host metabolism beyond nutrient absorption and immune modulation.

    Comparison with Existing Internal Articles

    Recent internal reviews, such as "Resazurin Sodium Salt: Transforming Translational Viability Assays", highlight the value of redox-sensitive viability reporters in dissecting metabolic activity in advanced cell models. In particular, Resazurin sodium salt is extensively used as a high-throughput, fluorogenic oxidation-reduction indicator to quantify cellular metabolic status and viability, enabling rapid assessment of mitochondrial function and cytotoxicity profiles in diverse experimental contexts. This complements the reference study’s use of mitochondrial readouts to dissect the impact of microbial H2S on L cell bioenergetics. Further, "Advanced Cell Viability Assay Insights" discusses troubleshooting strategies and optimization for fluorescence-based viability dyes in cancer and metabolic models, reinforcing the translational significance of robust, sensitive metabolic assays.

    Limitations and Transferability

    Although the findings establish a causal role for Desulfovibrio-derived H2S in impairing GLP-1 production and metabolic health in male mice, several limitations warrant consideration. The study focuses on male animals, thus sex-specific responses remain unexplored. Translation to human physiology requires confirmation that similar microbiota-hormone interactions occur in patients with metabolic syndrome. The use of bismuth subsalicylate as a microbial modulator, while clinically available, may have off-target effects or variable efficacy in humans. Additionally, the study’s focus on Desulfovibrio-H2S-L cell signaling may not capture the full complexity of microbiota-host metabolic crosstalk.

    Research Support Resources

    To support metabolic and redox biology workflows inspired by this research, Resazurin sodium salt (SKU B6098) is widely adopted as a sensitive fluorogenic oxidation-reduction indicator for assessing cell viability and mitochondrial function in both routine and advanced models. As described in internal resources and the product information, this reagent enables high-throughput viability, cytotoxicity, and metabolic assays, including applications in flow cytometry and fluorescence microscopy. Researchers designing experiments to probe mitochondrial bioenergetics or microbial-metabolite effects on cellular health can incorporate Resazurin sodium salt to quantitatively track redox changes and cellular viability. For optimal results, freshly prepared DMSO solutions are recommended, and care should be taken to avoid prolonged incubation or excessive concentrations, particularly in sensitive or cancer-derived cell lines.